Literature DB >> 22869589

Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Douglas J Kojetin1, Thomas P Burris.   

Abstract

Nuclear receptors are targets for a wide range of ligands, both natural and synthetic, that regulate their activity and provide a means to pharmacologically modulate the receptor. Recent emphasis in the nuclear receptor field has focused on selective nuclear receptor modulators, which can display graded transcriptional responses and tissue selective pharmacological responses that deviate from the prototypical agonist or antagonist. Understanding the molecular mechanism of action of these selective modulators will provide significant insight toward the development of the next generation of modulators. Although most nuclear receptor structural studies have primarily focused on obtaining ligand-receptor cocrystal structures, recent studies implicate an important role for protein dynamics in the mechanism of action of nuclear receptor ligands. Here we review nuclear receptor studies reporting how ligands modulate the conformational dynamics of the nuclear receptor ligand-binding domain (LBD). A particular emphasis is placed on protein NMR and hydrogen/deuterium exchange (HDX) techniques and how they provide complementary information that, when combined with crystallography, provide detailed insight into the function of nuclear receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869589      PMCID: PMC3533479          DOI: 10.1124/mol.112.079285

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  55 in total

Review 1.  Structural aspects of agonism and antagonism in the oestrogen receptor.

Authors:  A C Pike; A M Brzozowski; J Walton; R E Hubbard; T Bonn; J A Gustafsson; M Carlquist
Journal:  Biochem Soc Trans       Date:  2000       Impact factor: 5.407

2.  A dynamic mechanism of nuclear receptor activation and its perturbation in a human disease.

Authors:  Bettina C Kallenberger; James D Love; V Krishna K Chatterjee; John W R Schwabe
Journal:  Nat Struct Biol       Date:  2003-02

3.  Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.

Authors:  Lee Frego; Walter Davidson
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

4.  Methods for the Analysis of High Precision Differential Hydrogen Deuterium Exchange Data.

Authors:  Michael J Chalmers; Bruce D Pascal; Scooter Willis; Jun Zhang; Stephen J Iturria; Jeffery A Dodge; Patrick R Griffin
Journal:  Int J Mass Spectrom       Date:  2011-04-30       Impact factor: 1.986

5.  Molecular sensors of estrogen receptor conformations and dynamics.

Authors:  Anobel Tamrazi; Kathryn E Carlson; John A Katzenellenbogen
Journal:  Mol Endocrinol       Date:  2003-08-28

6.  Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.

Authors:  Joel P Berger; Ann E Petro; Karen L Macnaul; Linda J Kelly; Bei B Zhang; Karen Richards; Alex Elbrecht; Bruce A Johnson; Gaochao Zhou; Thomas W Doebber; Chhabi Biswas; Mona Parikh; Neelam Sharma; Michael R Tanen; G Marie Thompson; John Ventre; Alan D Adams; Ralph Mosley; Richard S Surwit; David E Moller
Journal:  Mol Endocrinol       Date:  2003-01-16

7.  Dynamics and ligand-induced solvent accessibility changes in human retinoid X receptor homodimer determined by hydrogen deuterium exchange and mass spectrometry.

Authors:  Xuguang Yan; David Broderick; Mark E Leid; Michael I Schimerlik; Max L Deinzer
Journal:  Biochemistry       Date:  2004-02-03       Impact factor: 3.162

8.  Deuterium exchange and mass spectrometry reveal the interaction differences of two synthetic modulators of RXRalpha LBD.

Authors:  Xuguang Yan; Efrén Pérez; Mark Leid; Michael I Schimerlik; Angel R de Lera; Max L Deinzer
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

9.  Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Authors:  John B Bruning; Michael J Chalmers; Swati Prasad; Scott A Busby; Theodore M Kamenecka; Yuanjun He; Kendall W Nettles; Patrick R Griffin
Journal:  Structure       Date:  2007-10       Impact factor: 5.006

10.  Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.

Authors:  Laura A Solt; Naresh Kumar; Philippe Nuhant; Yongjun Wang; Janelle L Lauer; Jin Liu; Monica A Istrate; Theodore M Kamenecka; William R Roush; Dušica Vidović; Stephan C Schürer; Jihong Xu; Gail Wagoner; Paul D Drew; Patrick R Griffin; Thomas P Burris
Journal:  Nature       Date:  2011-04-17       Impact factor: 49.962

View more
  31 in total

1.  Development of CINPA1 analogs as novel and potent inverse agonists of constitutive androstane receptor.

Authors:  Wenwei Lin; Lei Yang; Sergio C Chai; Yan Lu; Taosheng Chen
Journal:  Eur J Med Chem       Date:  2015-12-15       Impact factor: 6.514

2.  Quantitative structural assessment of graded receptor agonism.

Authors:  Jinsai Shang; Richard Brust; Patrick R Griffin; Theodore M Kamenecka; Douglas J Kojetin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-14       Impact factor: 11.205

Review 3.  Visualizing the Architectures and Interactions of Nuclear Receptors.

Authors:  Sepideh Khorasanizadeh; Fraydoon Rastinejad
Journal:  Endocrinology       Date:  2016-10-05       Impact factor: 4.736

Review 4.  State-of-the-art: functional fluorescent probes for bioimaging and pharmacological research.

Authors:  Lu Lu; Zhou-Yue Wu; Xin Li; Feng Han
Journal:  Acta Pharmacol Sin       Date:  2018-11-28       Impact factor: 6.150

5.  Structural Basis of Altered Potency and Efficacy Displayed by a Major in Vivo Metabolite of the Antidiabetic PPARγ Drug Pioglitazone.

Authors:  Sarah A Mosure; Jinsai Shang; Jerome Eberhardt; Richard Brust; Jie Zheng; Patrick R Griffin; Stefano Forli; Douglas J Kojetin
Journal:  J Med Chem       Date:  2019-02-07       Impact factor: 7.446

6.  Workflows and performances in the ranking prediction of 2016 D3R Grand Challenge 2: lessons learned from a collaborative effort.

Authors:  Ying-Duo Gao; Yuan Hu; Alejandro Crespo; Deping Wang; Kira A Armacost; James I Fells; Xavier Fradera; Hongwu Wang; Huijun Wang; Brad Sherborne; Andreas Verras; Zhengwei Peng
Journal:  J Comput Aided Mol Des       Date:  2017-10-06       Impact factor: 3.686

7.  Delineation of the molecular determinants of the unique allosteric binding site of the orphan nuclear receptor RORγt.

Authors:  Iris A Leijten-van de Gevel; Luc Brunsveld
Journal:  J Biol Chem       Date:  2020-05-20       Impact factor: 5.157

8.  First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated γ Coactivator 1-α Complex with Endogenous and Synthetic Glucocorticoids.

Authors:  Xu Liu; Yashuo Wang; Eric A Ortlund
Journal:  Mol Pharmacol       Date:  2019-08-07       Impact factor: 4.436

9.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

Review 10.  Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer.

Authors:  Sergio C Chai; William C Wright; Taosheng Chen
Journal:  Med Res Rev       Date:  2019-11-28       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.